Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
From the editor: The role of generalists in clinical lipidology.
Guyton, John R.
J Clin Lipidol ; 17(2): 197, 2023.
Article in English | MEDLINE | ID: covidwho-2296011
2.
From the editor: Eglerio! The Ringbearers, praise them!
Guyton, John R.
J Clin Lipidol ; 16(3): 247-248, 2022.
Article in English | MEDLINE | ID: covidwho-1926577
3.
From the editor: Connectedness and lipidology.
Guyton, John R.
J Clin Lipidol ; 14(5): 611, 2020.
Article in English | MEDLINE | ID: covidwho-1415501

Subject(s)
Communication , Interpersonal Relations , Lipids , COVID-19/epidemiology , COVID-19/psychology , Humans , Lipid Metabolism , Pandemics , Periodicals as Topic
4.
From the editor: From a hell of a year to "Hello Telemedicine".
Guyton, John R.
J Clin Lipidol ; 15(3): 383-384, 2021.
Article in English | MEDLINE | ID: covidwho-1281438

Subject(s)
Dyslipidemias/therapy , Telemedicine , Humans
5.
From the editor: Rounding the corner.
Guyton, John R.
J Clin Lipidol ; 15(1): 1, 2021.
Article in English | MEDLINE | ID: covidwho-1108378

Subject(s)
Lipid Metabolism , Periodicals as Topic
6.
From the editor: Moral choices and human health.
Guyton, John R.
J Clin Lipidol ; 14(6): 743-744, 2020.
Article in English | MEDLINE | ID: covidwho-1023625

Subject(s)
Choice Behavior , Health , Morals , Humans
7.
From the editor: Never send to know for whom the bell tolls.
Guyton, John R.
J Clin Lipidol ; 14(4): 381-382, 2020.
Article in English | MEDLINE | ID: covidwho-755657

Subject(s)
Lipids , Research , COVID-19/epidemiology , Humans , Pandemics
8.
From the editor: Plagues and the ancient legacy of Epimenides.
Guyton, John R.
J Clin Lipidol ; 14(3): 271-272, 2020.
Article in English | MEDLINE | ID: covidwho-825843

Subject(s)
COVID-19/epidemiology , Humans , Pandemics
9.
From the editor: Confronting a pandemic or two.
Guyton, John R.
J Clin Lipidol ; 14(2): 159, 2020.
Article in English | MEDLINE | ID: covidwho-825842

Subject(s)
Hyperlipoproteinemia Type II , Pandemics , Antibodies, Monoclonal , Cholesterol, LDL , Consensus , Goals , Humans , India , Proprotein Convertase 9 , Secondary Prevention
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL